α-Difluoromethylornithine and polyamine levels in the human prostate: Results of a phase IIa trial

Journal of the National Cancer Institute

Volumn 93, Issue 1, 2001, Pages 57-59

  Simoneau, Anne R ^a,b   Gerner, Eugene W ^c   Phung, Mai ^d   McLaren, Christine E ^b   Meyskens Jr , Frank L ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE DECARBOXYLASE; PLACEBO; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; HOSPITAL; HUMAN; IN VIVO STUDY; INFORMED CONSENT; MALE; NEEDLE BIOPSY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAMPLE; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0035798797     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.1.57     Document Type: Article

References (19)

1. Cancer surveillance series: Interpreting trends in prostate cancer-part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality
2. Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans
3. Ornithine decarboxylase as a biologic marker in familial colonic polyposis
4. Ornithine decarboxylase activity in Barrett's esophagus: A potential marker for dysplasia
5. Inhibition of tumor promotion by DL-alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase
6. Altered polyamine profiles in prostatic hyperplasia and in kidney tumors
7. Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues
8. Effects of α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on testosterone-induced regeneration of prostate and seminal vesicle in castrated rats
9. Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor α-difluoromethylornithine
10. The growth of MAT-LyLu rat prostatic adenocarcinoma can be prevented in vivo by polyamine deprivation
11. Low-dose difluoromethylornithine and polyamine levels in human prostate tissue
12. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps
13. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention
14. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine
15. Polyamine measurements in the uterine cervix
16. Cell transformation, invasion, and angiogenesis: A regulatory role for ornithine decarboxylase and polyamines?
17. Development of difluoromethylornithine (DFMO) as a chemoprevention agent
18. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging